Chava Perry

3.5k citations
110 papers · 2.8k · 1 hit paper · h-index 27

Impact in

Papers in

Chava Perry

107 papers receiving 2.7k citations

Chava Perry's Hit Papers

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia 2021 · 515 citations
5150+1+3Years since publication100200300400500

Peers

Chava Perry
Comparison fields: 5 of 108
  • Infectious Diseases 812
  • Pathology and Forensic Medicine 539
  • Genetics 254
  • Oncology 446
  • Biological Psychiatry 25
Replace Luis Llorente with:
Luis Llorente Mexico
JoAnn Trial United States
Cristina Maria Costantino United States
Kazuhisa Nakano Japan
Carlo Tornatore United States
Srinivas Mummidi United States
Tarra L. McDowell United Kingdom
Clio P. Mavragani Greece
Rachel Chicheportiche Switzerland
Annette E. Maluish United States
Chava Perry relative to Luis Llorente Mexico Luis Llorente's profile →
Citations per field
00.5×2×4×5.9×
Luis Llorente · 1×
Citations per year

Countries citing papers authored by Chava Perry

Since Specialization
Citations

This map shows the geographic impact of Chava Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chava Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chava Perry more than expected).

Fields of papers citing papers by Chava Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chava Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chava Perry. The network helps show where Chava Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Chava Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chava Perry Line = papers co-authored together Chava Perry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Hit paper breakdown →
2021515
2 2005138
3 2021130
4 2021123
5 1997103
6 200797
7 201780
8 200279
9 200273
10 200373
11 200464
12 202164
13 200260
14 200660
15 202158
16 200755
17 200552
18 202147
19 200245
20 201242

About Chava Perry

Chava Perry is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Infectious Diseases, having authored 110 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (24 papers), CAR-T cell therapy research (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (7 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Infectious Diseases (812 citations), Pathology and Forensic Medicine (539 citations), Genetics (254 citations), Oncology (446 citations) and Biological Psychiatry (25 citations). Chava Perry has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Yair Herishanu, Hermona Soreq, Irit Mazza Avivi, Gabi Shefer, Aaron Polliack, M. Morales, Erel Joffe, Yotam Bronstein, Anat Aharon and Shai Levi. Their work appears in journals such as Blood, European Journal Of Haematology, Annals of Hematology, Leukemia Research and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact